InvestorsHub Logo
Followers 58
Posts 10044
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Friday, 11/24/2023 9:21:21 AM

Friday, November 24, 2023 9:21:21 AM

Post# of 458512

Data from the blarcamesine in Alzheimer’s disease Phase 2b/3 randomized clinical trial will be published in an upcoming peer-reviewed journal.



https://www.anavex.com/post/anavex-life-sciences-to-announce-fiscal-2023-year-end-financial-results-on-monday-november-27-2023?mc_cid=a5824b7d7e&mc_eid=0688b12ec0
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News